Table 2.
Comparative Analysis of Indications for Liver Transplantation Between Two Study Periods.
| Disease aetiology | Period 1 (n = 277) (%) |
Period 2 (n = 740) (%) |
P value |
|---|---|---|---|
| NASH | 85 (30.7%) | 311 (42%) | 0.001 |
| Hepatitis B | 45 (16.2%) | 104 (14.1%) | 0.550 |
| Hepatitis C | 49 (17.7%) | 75 (10.1%) | 0.002 |
| Alcohol | 62 (22.4%) | 137 (18.5%) | 0.183 |
| Autoimmunea | 14 (5.1%) | 60 (8.1%) | 0.104 |
| Othersb | 22 (7.9%) | 53 (7.2%) | 0.089 |
| HCC | 52 (18.8%) | 147 (19.9%) | 0.723 |
NASH, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma.
a
Autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis and overlap syndrome.
b
Drug-induced liver injury, Budd Chiari syndrome, failed Kasai, and Wilson’s disease.